findmyKOL

William Abraham, MD

Enriched profile

Chief Medical Officer, Cardiac Dimensions · Cardiac Dimensions

ORCIDNPI
Region🇺🇸 Columbus, OH · Midwest · United StatesSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusHeart Failure Treatment and Management+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2002–2020

William Abraham is Chief Medical Officer, Cardiac Dimensions at Cardiac Dimensions. OpenAlex indexes 1,140 publications with 95,147 citations (h-index 136); ClinicalTrials.gov lists 23 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Advanced Heart Failure and Transplant Cardiology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

William T. Abraham, MD, is Chief Medical Officer, Cardiac Dimensions. The public record shows 1,140 publications with 95,147 citations (h-index 136), centered on Heart Failure Treatment and Management, Cardiac pacing and defibrillation studies, Cardiovascular Function and Risk Factors. It also documents an investigator role on 23 registered clinical trials, industry payments reported by 10 companies, 3 NIH-funded awards (2002–2020).

  • Most recent indexed publication: 2026 · ESC heart failure
  • Top research focus: Heart Failure Treatment and Management
  • 23 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 10 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure19 trialsApnea2 trialsMitral Valve Insufficiency2 trialsAtrial Fibrillation1 trialArrhythmias, Cardiac1 trialSleep Apnea, Central1 trialHypertension1 trialSleep Apnea Syndromes1 trial

Research focus

OpenAlex concept fingerprint
Heart Failure Treatment and ManagementCardiac pacing and defibrillation studiesCardiovascular Function and Risk FactorsMechanical Circulatory Support DevicesCardiac Valve Diseases and Treatments

Drugs & molecules

across trials, industry payments and publications
Jardiancegeneric · EmpagliflozinClinical trialsIndustry payments1Publications1Furoscixgeneric · FurosemideClinical trialsIndustry payments13Publications

Works with

trial sponsors and companies reporting payments
CVRx, Inc.Clinical trials4Industry payments2Sensible Medical Innovations Ltd.Clinical trials1Industry payments4ZOLL Respicardia, Inc.Clinical trialsIndustry payments29

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,140publications

Distinct works indexed by OpenAlex, matched via ORCID; 26 in PubMed.

95,147citations

Total citations across indexed works.

136h-index

Hirsch index (OpenAlex). i10-index 536.

Clinical & industry

trials, payments and federal funding
23clinical trials

Investigator role on registered studies.

View trials
10companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
3NIH grants · 2002–2020

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 23 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    84.8%
    Beta blocker20%
    Carvedilol100%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)15.2%
    Losartan Potassium100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    15.2%
    SGLT2 inhibitor15.2%
    Jardiance100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

3 NIH research awards on record, funded 20022020 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/william-abraham-8286277

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com

Mentions by others

where others cite or feature them
  • Spotify

    open.spotify.com/show/3qJvoSLbt38xUiJETqhnQC

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship

    Cardiovascular Disease, University of Colorado at Denver

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wexnermedical.osu.edu
  • Residency

    Internal Medicine, University of Colorado at Denver

    1990
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wexnermedical.osu.edu
  • MD

    Harvard Medical School

    1986
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wexnermedical.osu.edu
  • Board Certification

    American Board of Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wexnermedical.osu.edu
  • Board Certification

    American Board of Internal Medicine / Cardiovascular Disease

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wexnermedical.osu.edu
  • Board Certification

    American Board of Internal Medicine / Advanced Heart Failure-Transplant Cardiology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wexnermedical.osu.edu

Editorial & leadership roles

journal and society appointments
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record
3 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.